Plain-English translation of NCT07269457 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether vitamin D3 supplements can help your brain recover after a head injury by reducing inflammation and swelling. After a head injury, your brain can develop secondary damage from inflammation and stress, which is a major cause of long-term disability. Researchers want to see if this medication can help prevent that secondary damage and improve your overall recovery.
Right now, there are no proven medications that can stop the inflammatory damage that happens after a head injury. This study exists because vitamin D has shown promise in laboratory research for reducing brain inflammation and protecting nerve tissue, but it has never been tested in a rigorous clinical trial in patients like you.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either vitamin D3 supplements or a placebo (a dummy pill) for 3 weeks, with doses depending on your baseline vitamin D levels. You will have follow-up visits and blood tests to measure inflammation markers and track your recovery over 24 weeks total. The study is designed so that neither you nor your doctors will know which treatment you're receiving, to ensure fair results.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Nigeria